Michael Tesar

1.7k total citations
36 papers, 1.4k citations indexed

About

Michael Tesar is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Michael Tesar has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Radiology, Nuclear Medicine and Imaging, 18 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Michael Tesar's work include Monoclonal and Polyclonal Antibodies Research (20 papers), CAR-T cell therapy research (10 papers) and Viral Infections and Immunology Research (7 papers). Michael Tesar is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (20 papers), CAR-T cell therapy research (10 papers) and Viral Infections and Immunology Research (7 papers). Michael Tesar collaborates with scholars based in Germany, United States and France. Michael Tesar's co-authors include Otfried Marquardt, Wolf‐Rainer Abraham, Edward R. B. Moore, Kenneth N. Timmis, Donald F. Summers, Ellie Ehrenfeld, Oliver Pelz, Antoni Bennasar-Figueras, Peter Lowe and Sven Berger and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Michael Tesar

35 papers receiving 1.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Michael Tesar 667 360 258 247 243 36 1.4k
Stéphanie Durand 676 1.0× 396 1.1× 369 1.4× 42 0.2× 72 0.3× 50 1.3k
H Fan 837 1.3× 140 0.4× 470 1.8× 61 0.2× 46 0.2× 74 2.2k
Xiaomei Bai 1.0k 1.5× 96 0.3× 222 0.9× 108 0.4× 45 0.2× 26 2.0k
Wenli Zhang 764 1.1× 71 0.2× 120 0.5× 111 0.4× 35 0.1× 105 1.7k
Arturo Falaschi 2.9k 4.3× 85 0.2× 191 0.7× 198 0.8× 914 3.8× 103 3.9k
Takeaki Taniguchi 1.4k 2.0× 170 0.5× 618 2.4× 461 1.9× 23 0.1× 30 2.2k
Brian E. Huber 1.6k 2.4× 121 0.3× 217 0.8× 164 0.7× 17 0.1× 63 2.9k
Lu Gao 724 1.1× 71 0.2× 106 0.4× 40 0.2× 52 0.2× 38 1.7k
Sébastien Carrère 979 1.5× 44 0.1× 46 0.2× 176 0.7× 85 0.3× 128 4.1k
Donna Smoler 462 0.7× 36 0.1× 126 0.5× 100 0.4× 130 0.5× 12 903

Countries citing papers authored by Michael Tesar

Since Specialization
Citations

This map shows the geographic impact of Michael Tesar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Tesar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Tesar more than expected).

Fields of papers citing papers by Michael Tesar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Tesar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Tesar. The network helps show where Michael Tesar may publish in the future.

Co-authorship network of co-authors of Michael Tesar

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Tesar. A scholar is included among the top collaborators of Michael Tesar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Tesar. Michael Tesar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Reusch, Uwe, Kristina Ellwanger, Ivica Fucek, et al.. (2022). Cryopreservation of Natural Killer Cells Pre-Complexed with Innate Cell Engagers. Antibodies. 11(1). 12–12. 9 indexed citations
3.
Ellwanger, Kristina, Uwe Reusch, Ivica Fucek, et al.. (2017). Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies. Frontiers in Oncology. 7. 100–100. 25 indexed citations
4.
Koch, Joachim & Michael Tesar. (2017). Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy. Transfusion Medicine and Hemotherapy. 44(5). 337–350. 18 indexed citations
5.
Boute, Nicolas, Peter Lowe, Sven Berger, et al.. (2016). NanoLuc Luciferase – A Multifunctional Tool for High Throughput Antibody Screening. Frontiers in Pharmacology. 7. 27–27. 54 indexed citations
6.
Nagy, Zoltan A., Bernd Hubner, Robert Rauchenberger, et al.. (2002). Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells. Nature Medicine. 8(8). 801–807. 122 indexed citations
7.
Krebs, Barbara, Robert Rauchenberger, Silke U. Reiffert, et al.. (2001). High-throughput generation and engineering of recombinant human antibodies. Journal of Immunological Methods. 254(1-2). 67–84. 130 indexed citations
8.
9.
Pelz, Oliver, Michael Tesar, Rolf‐Michael Wittich, et al.. (1999). Towards elucidation of microbial community metabolic pathways: unravelling the network of carbon sharing in a pollutant‐degrading bacterial consortium by immunocapture and isotopic ratio mass spectrometry. Environmental Microbiology. 1(2). 167–174. 119 indexed citations
10.
Schmidt, Alexej, Michael Tesar, Martin Welschof, et al.. (1998). Monitoring of scFv selected by phage display using detection of scFv–pIII fusion proteins in a microtiter scale assay. Journal of Immunological Methods. 220(1-2). 51–58. 19 indexed citations
11.
Beckmann, Christiane, et al.. (1998). Multifunctional g3p-peptide tag for current phage display systems. Journal of Immunological Methods. 212(2). 131–138. 12 indexed citations
12.
Jia, Xiaoteng, Michael Tesar, Donald F. Summers, & Ellie Ehrenfeld. (1996). Replication of hepatitis A viruses with chimeric 5' nontranslated regions. Journal of Virology. 70(5). 2861–2868. 17 indexed citations
13.
14.
Tesar, Michael, et al.. (1994). Expression of Hepatitis A Virus Precursor Protein P3 in Vivo and in Vitro: Polyprotein Processing of the 3CD Cleavage Site. Virology. 198(2). 524–533. 27 indexed citations
15.
Tesar, Michael, et al.. (1993). Analysis of a Potential Myristoylation Site in Hepatitis A Virus Capsid Protein VP4. Virology. 194(2). 616–626. 36 indexed citations
16.
Tesar, Michael, Shirley A. Harmon, Donald F. Summers, & Ellie Ehrenfeld. (1992). Hepatitis A virus polyprotein synthesis initiates from two alternative AUG codons. Virology. 186(2). 609–618. 39 indexed citations
17.
Tesar, Michael, et al.. (1991). Detection of hepatitis A virus proteins in infected BS-C-1 cells. Virology. 185(1). 411–418. 20 indexed citations
18.
Tesar, Michael & Otfried Marquardt. (1990). Foot-and-mouth disease virus protease 3C inhibits cellular transcription and mediates cleavage of histone H3. Virology. 174(2). 364–374. 61 indexed citations
19.
20.
Tesar, Michael, et al.. (1989). Serological probes for some foot-and-mouth disease virus nonstructural proteins. Virus Genes. 3(1). 29–44. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stéphanie Durand Breakdown of academic impact, for papers by H Fan Breakdown of academic impact, for papers by Xiaomei Bai Breakdown of academic impact, for papers by Wenli Zhang Breakdown of academic impact, for papers by Arturo Falaschi Breakdown of academic impact, for papers by Takeaki Taniguchi Breakdown of academic impact, for papers by Brian E. Huber Breakdown of academic impact, for papers by Lu Gao Breakdown of academic impact, for papers by Sébastien Carrère Breakdown of academic impact, for papers by Donna Smoler
Rankless by CCL
2026